On the other hand, a qPCR analysis using mouse-specific primers revealed that the expression of VEGFA, FGF2, FGFR2 and platelet-derived growth factor receptor A (PDGFRA) was upregulated in the bevacizumab-treated tumour stroma (Fig. 2a). The gene discussed is FGFR2; the disease is neoplasm.